LongevityLeak

Glucose metabolism and redox support

Alpha-Lipoic Acid (ALA)

Alpha-lipoic acid may improve insulin sensitivity and glycemic markers, with larger effects in people with higher baseline metabolic risk.

Evidence Level B

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Clinical Snapshot

Effect Size
Modest glucose-control and oxidative-stress support
Safety
Moderate Risk

Can lower blood glucose and should be coordinated with glucose-lowering medication use.

Research Dosing

This reflects common ranges and protocols used in published studies, not personal medical advice.

Typical Daily Dose
300-600 mg
Timing
With meals or split dosing
Protocol Duration in Studies
8-16 weeks in metabolic studies

Lower initial dosing may reduce GI side effects.

Best Fit Profiles

  • metabolic resilience protocols

Source Links